A Cameroonian patient with antibodies reacting simultaneously to human immunodeficiency virus type 1 (HIV-1) group O-and group M-specific v3-100~ peptides was identified. In order to confirm that this patient was coinfected with both viruses, PCRs with O-and M-specific discriminating primers corresponding to different regions of the genome were carried out with both primary lymphocyte DNA and the corresponding viral strains isolated from three consecutive patient samples. The PCR data suggested that this patient is coinfected with a group M virus and a recombinant M/O virus. Indeed, only type M gag sequences could be amplified, while for the env region, both type M and O sequences were amplified, from plasma or from DNA extracted from primary lymphocytes. Sequence analysispf a complete recombinant genome isolated from the second sample (97CA-MP645 virus isolate) revealed two intergroup breakpoints, one in the vpr gene and the second in the long terminal repeat region around the TATA box. Comparison of the type M sequences shared by the group M and the recombinant MIO viruses showed that these sequences were closely related, with only 3% genetic distance, suggesting that the M virus was one of the parental viruses.
Phylogenetic analysis of human immunodeficiency type 1 ( W -1 ) isolates from dXerent geographic locales has revealed that HIV-1 can be divided into at least three distinctive groups, M, N, and O (41) . Group M, the major group, comprises the majority of the HIV-1 strains responsible for the AIDS epidemic worldwide and can be further subdivided into at least 10 different genetic envelope subtypes (A to J) approximately equidistantly related, with intrasubtype divergence of up to 20% and intersubtype divergence of between 25 and 35% for the Env amino acid sequences (39) . The genetic diversity results mainly from the error-prone nature of the viral reverse transcriptase and from the in vivo selection of variants (33) . HIV-1 group O isolates represent a minority of the HXV-1 isolates and have only 50% homology with the HIV-1 group M isolates in the env gene (16, 45) . HIV-1 group O seems to be endemic in West Central Africa, especially Cameroon, where the frequency of infection is estimated to be 2 to 5% of HIV-1-infected individuals (27, 31, 32) . Group N viruses, recently reported for two Cameroonian patients only, are equidistant to group M and O strains (41) .
Infections with KIV-1 isolates from group O present a public health problem because antibodies against them might not be detected (26, 36) . Commercial viral load assays are still not I .peeters@mpl.ird.fr. (25) , and in vitro data showed that HIV-1 group O viruses are naturally resistant to nonnucleoside reverse transcriptase inhibitors, as is HIV-2 (7, Within group M, not all subtypes are pure or nonrecombinant. At least one'full-length isolate characterized as a nonrecombinant has been sequenced for subtypes A, B, C, D, F, and H (21) . Recombination events among sequences of different genetic subtypes of HlV-1 group M have been frequently identified. Indeed, up to 20% of the genomes that have been completely sequenced revealed a mosaic structure comprising fragments from two or more genetic subtypes (13) . AU representatives of subtypes E and G sequenced to date represent mosaic genomes, with parts of the genome clustering with subtype A viruses and other parts forming clearly distinguishable clades designated E and G (4, 5, 13, 14) . In certain populations and regions where multiple HIV-1 subtypes cocirmlate, many combinations of intersubtype recombinant viruses have been documented (A/C, AID, BE, AIGiH, and NGD) (12, 21, 34) . Therefore, recombination may play a significant role in global KIV evolution, creating novel viral genotypes within given human populations.
Recombination requires the simultaneous infection of a cell with two different proviruses, allowing the encapsidation of one RNA transcript from each ProVirus into a heterozygous virion. After the subsequent infection of a new cell, the reverse transcriptase, by jumping back and forth between the two RNA templates, will generate a newly synthesized retroviral DNA sequence that is recombinant between the two parental genomes (17) . Recombinant viruses may have some advantages over the parental strain, including eventual modifications of tropism and replication efficiency (fitness).
The first epidemiologic studies, conducted from 1988 to 1993, reported a low prevalence of HIV infection in Cameroon (29) . However, since then, the reported incidence of AIDS cases increased, and this correlates well with the increased incidence and prevalence found in sentinel populations. For example, from 1985 to 1995, the seroprevalence rates of HIV infection i n pregnant women and in students increased from 0.3 to 4.0%, with the highest rates in cities (28) .
Recent reports have outlined a paradoxically great diversity of HIV-1 strains in Cameroon, including almost all of the group M subtypes, intersubtype recombinant viruses, and to a lesser extent the highly divergent HIV-1 group O viruses and also the recently discovered group Nviruses (16, 30, 41, 42, 45) .
Here we provide a comprehensive genetic analysis of an HIV-1 intergroup recombinant that arose in vivo. This intergroup M/O KIV-1 recombinant was isolated from a patient belonging to a cohort of HIV-1-infected patients initiated to study the impact of HIV-1 group M or group O viruses on disease development and pathogenicity. The characterization of this recombinant virus, which is highly replicative in vitro, illustrates the continuous emergence of new HIV-1 variants that are likely to be transmissible.
MATERIALS AND METHODS
Detection of antibodies against group O HIV-1. The discrimination between group O and M viruses was done by serology2 with all of the sera being tested for group O antibodies by an enzyme-linked immunosorbent assay with a combmation of V3 peptides from HIV-I, , and HIV-1bm,,80 (Research Product; Innogenetics, Antwerp, Belgium). Sera reactive in the enzyme-linked immunosorbent assay were retested in a line immunoassay, in which biotinylated V3 peptides from different group O and group M HIV-1 isolates (M-consensus, M-Mal, O-ANT70, O-VI686, and O-MVP5180) were applied as a streptavidm complex in parallel lines on nylon skips (Research Producc Innogenetics) (32) . Viral isolation and biological phenotype. Peripheral blood mononuclear cells (PBMCs) from the HIV-positive patients were cocultivated with phytohemagglutinin (PHA)-stimulated lymphocytes from a healthy (HIV-negative) human donor in RPMI 1640 medium (Biowhittaker, Verviers, Belgium) supplemented with 15% heat-inactivated fetal calf serum (Gibco, Paisley, Scotland), 0.03% L-glutamine (Gibco), 2 pg of Polybrene (Murex, Dartford, England) per ml, antibiotics, and 20 U of recombinant interleukin-2 (Boehringer, Mannheim, Germany) per m l . The release of viral particles in the culture supernatant was examined by an HIV p24 antigen-capturing test (Innogenetics).
Syncytium formation by the HIV-1 isolates was determined with the MT-2 assay essentially as described by Koot et al. (20) . HIV-1 strains obtained from the initial culture were propagated by short-term passage (7 to 10 days), and then 1 million infected PBMCs were cocultivated with 2 million MT-2 cells at a concentration of 500,000 cells per ml. HIV-1 cultures were considered to exhibit syncytia if one multinucleated giant cell per field of the light microscope was observed.
Biologieal cloning. Biological clones were generated by means of a direct limiting-dilution technique from the cultured PBMCs at the third positive time point in the p24 HIV-1 antigen-capturing test. Briefly, in a 96-well microtiter plate, 100-pl volumes containing loo, I O ' , IO2, lo3, and IO4 cocultured patient PBMCs were cocultivated with 100 pl containing IO5 3-day PHA-stimulated donor PBMCs in RPMI 1640 medium (Biowhittaker) containing 15% inactivated fetal calf serum (Gibco), 20 U of recombinant interleukin-2 (Boehringer) per m l , 0.03% glutamine (Gibco), 2 pg of Polybrene (Murex) per m l , and antibiotics.
The cultures were kept at 3TC in a 5% CO, incubator for 4 weeks. Culture Supernatants from each well were tested for the expression of p24 antigen once a week by an HIV-1 p24 antigen-capturing assay (Innogenetics). The cultures were refed with fresh medium twice a week, and fresh PHA-stimulated donor PBMCs (lo4) were added once a week When fewer than 37% of the wells were positive for p24 antigen expression after 4 weeks of cdture, the ceUs in these wells were assumed to be infected with a single virus according to the Poisson distribution (22, 37) . HIV-1 clones were then expanded, and the PBMCs and supernatants were cryopreserved at -80°C until use.
Detection of gronp O or group M EUV-l. A group M fragment of the envelope was amplified with a nested PCR by using as outer primers the A and N primers previously described (11) to a m p l i the entire @I60 region and as inner primers ED3-ED14, previously described for subsequent genetic subtyping by the heteroduplex mobility assay and to amplify specifically group M viruses (6) . The amplification reaction was performed with the Expand high-fidelity PCR system accordmg to the instructions of the manufacturer (Boehringer Mannheim, Indianapolis, Ind.).
A nested PCR was necessary to amprify the accessow gene region. The outer primers (sense, VIF-I; antisense, WU-1) allow amplification of HIV-1 from groups O and M (la). PCRs were carried out in a final volume of 100 pl containing 10 mM Tris-Hc1 (pH 9.0), 50 mM KCI, 1.5 mM MgCI,, 0.2 mM each deoxynucleoside tiphosphate, 2.5 U of Taq DNA polymerase (Promega), and 0.4 pM each primer. The PCR rounds consisted of 35 cycles with a denaturing step at 94°C for 30 s, an annealing step at 50°C for 30 s, and an elongation step at 72°C for 2 min. The inner primers were specific for either group O (sense, O-vif; antisense, O-vpu) or group M (sense, M-vif; antisense, M-yu). The PCR conditions were similar to those described for the first round.
To amplify a group M fragment of 700 bp in thegug gene, corresponding to the p24 region, a nested PCR was done with previously described primers GOO and GOI as outer primers and G60 and G25 as inner primers (35) .
To ampIify a group O fragment in thegag-pol region, a nested PCR was done with previously described primers GAGCAM-EX5 (7) and Hpol 4481 (IO) as outer primers and GAGCAM-IN5 and POLCAM52 (7) as inner primers. The amplification reaction was performed with the Expand high-fidelity PCR system according to the instructions of the manufacturer (Boehringer Mannheim).
Cloning and sequencing. Sequencing of the different amplified fragments was done either directly or after cloning. For direct sequencing the ampliied DNA was purified by using a QiaQuick gel extraction kit (QIAGEN S.A., Courtaboeuf, France). Cycle sequencing was performed with fluorescent dye terminator technology (dye terminator cycle sequencing with AmpliTaq DNA polymerase FS [Perkin-Elmer, Roissy, France]) according to the instructions of the manufacturer. Electrophoresis and data collection were done on an Applied Biosystems 373A automatic DNA sequencer.
Some PCR fragments were purified with the QIAquick PCR ptuification kit (QIAGEN S.A.), cloned with the TOPO-XL-PCR cloning kit (Invitrogen, Leek, The Netherlands), and then sequenced.
Overlapping sequence fragments were assembled by using SeqEd (Applied Biosystem, Inc.) to generate the full-length sequence of the complete viral genome.
Phylogenetic analysis and recombination analysis. Nucleotide sequences were aligned by using CLUSTAL. W (43) with minor manual adjustments, considering the protein sequences. Regions that could not be aligned unambiguously, due to length or sequence variability, were omitted from the analysis. Phylogenetic trees obtained with the neighbor-joining method and reliability of the branching orders obtained with the bootstrap approach were implemented by using CLUSTAL W. Genetic distances were calculated with Kimura's two-parameter method (19) . ' In order to analyze whether the viruses were recombinant in the sequenced regions, several additional analysis were performed the Recombinant Identification Program (RIP) (40) , available on-line through the Los Alamos Database (23a); diversity plotting (DIVERT), available on-line through the Agence National de Recherche sur le SIDA (ANRS) website (1); and Blast subtyping, available on-line through the National Center for Biotechnology Information website (2%). Informative site analysis (13) was done to estimate the locations and the significance of crossovers. The putative hybrid sequence was compared with a representative of each of the two I-JIV-1 groups inferred to have been involved in the recombination event and an appropriate Outgroup. Phylogenetically informative sites in this context are those at which four taxa are divided equally into two groups, each of which has identity at that site. Each informative site supports one of the three possible phylogenetic relationships among the four taxa, and a cluster analysis maximizing the value of A? is then used to select breakpoints among the clusters. P values for the resultant divisions were calculated by the Fisher exact test. These breakpoints were used to divide the alignment into segments for phylogenetic tree construction as described above. The positions of the breakpoints were confirmed by phylogenetic tree analysis of the corresponding regions.
Nucleotide sequence accession numbers. Virus was isolated from the three sequential blood samples taken from this patient. The biological phenotype on MT-2 cells was non-syncytium inducing for the three consecutive viruses isolated from this patient.
HN-1 group O-and group M-specific PCRs. In order to confirm whether the dual Ml0 seropositivity in this patient was due to a coinfection with HIV-1 group O and group M viruses, PCRs with group O-and group M-specific discriminating primers were performed for different regions of the genome. These PCRs were done with DNA extracted from primary l p p h ocytes and the corresponding viral strains of the three consecutive samples from this patient. Table 2 summarizes the results obtained with the different primer sets for the different genomic regions on primary and cultured PBMCs.
In primary PBMCs, the gag, pol, and accessory gene regions , could be ampliied only with group M-specific primers, whereas the envelope region was simultaneously amplified with group O-and group M-specific primers. For the corresponding viral isolates, group M-specific primers also amplified only the gag-pol region, but only group O-specific primers could amplify the envelope region, and the accessory gene region remained negative with group O-and group M-specific primers. These data showed that in primary PBMCs group' O-and group M-type envelopes were simultaneously present, while in gag, pol, and the accessory genes only type M sequences could be detected. However, in the viral populations obtained after coculture, only group M gag and pol fragments and group O env sequences were detected. These data suggested that this patient is coinfected with a group M virus and a recombinant group M/group O virus. Since on cultured virus, neither group O-nor group M-specific primers could a m p l i the accessory gene region, we suspected that the recombination event OC- A group M-specific primer was used for the 5' end, and a group O-specific primer was used for the 3' end.
one sample (the 97CA-MP645 virus isolate) has been sequenced. Four different but overlapping fragments spanning the entire genome were amplified and subsequently sequenced pol-gp41, gp41-long terminal repeat (LTR), LTRgag, and gag-vpu. Diversity plotting, RIP analysis, and Blast subtyping clearly revealed a recombinant group M/O virus with two intergroup breakpoints, one in the vpr region, which confirms the PCR results, and a second in the LTR region. The phylogenetic analysis described below indicated that the group M sequence is close to the HIV-lmNG sequence, an A/G intersubtype recombinant virus originating in Nigeria (4). Figure  1 shows the diversity plot analysis which indicates the two intergroup breakpoints of the 97CA-MP645 complete genome Tf?e positions of the breakpoints were confirmed by phylogenetic tree analysis: the gag-pol-vif fragment of the recombinant 97CA-MP645 strain clusters with the H1V-lmNG strain (Fig. 3A) , whereas the fat-vpu-em-nef fragment clusters with the group O viruses (data not shown). Figure 3B shows the phylogenetic analysis of the entire envelope region (gp160) of the intergroup M/O recombinant virus compared to reference strains of HIV-1 group M and group O. The gp160 sequence of our recombinant M/O 97CA-MP645 strain clusters with the ANT-70 virus. The N G intersubtype breakpoints in the gag-pol region are similar to those observed for the HIV-lIBNG strain (data not shown). The intergroup M/O breakpoints in the vpr and LTR genes were confirmed for the primary PBMCs and the viral strains from the three consecutive samples by specific PCRs followed by sequence analysis of 800 and 1,700 bp, respectively.
Partial sequence analysis of the parental HlV-1 group M strain. For the accessory gene region, a group M fragment could be amplified with the specfic primers only for prhnary PBMCs. This group M fragment was amplified by a nested PCR with outer primers VIF-1 and VPU-1, which can amplify group O and M sequences in this region, followed by a second round with group M-specific primers M-vif and M-vpu. Sequence and phylogenetic analyses showed that this fragment A A C A A G C C C C A G A A G A C C A G G G G G C A C A G A G G G A G A T~T A~~T A T   ....................... C -. . . . . . . . . . G . . . . . . . . T . . . . . . . . . . . . C -. . . . -. . . . A . . . . . .   .. A . . . G C A . . . . . A . . A . . . . . . . . C . . . . . . . . . . . . . . A . -C . C C . . G . . . -. . . . C . . T . . . . . . . . T . . .   ...................................................................... . T . . ...... G . . . A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T . . . . . G T T . . . . . C . . . . . . . . G  ..... C . . T . . . . T . . . . . . . A T G . . A . . T . . . . . . . . C . . A . . . . . . T . G . . . . . . . . . . . . . A . . . . . . . . . . C A G C G G G G G C m C C A G T -~~G -G G G C G G T P C   . T . . . . . . A . . . . . . . . --. . -. . . -. --G . . . . . . . . . . . . . . . . . . . . . . . . -A . . . . . . . -. A . . . -. . T . . . . C . . . . c . . . . . . . . . . . . . . . . . . . . . . . . . . c . . . . . . . . . . . . . . . clusters in this region of the genome with the HIV-lDNG strain (Fig. 4A) , as was previously seen for the group M gag-pol sequences from the M/O recombinant virus. Comparison of the common group M fragment (vifvpr) between the group M and W O viruses showed that these sequences were closely related, with a genetic distance of 396, calculated by the Kimura two-parameter method (19) by using the same sequences as in the phylogenetic tree. A group M envelope fragment was also amplified i n primary PBMCs; however, the signal was weaker than that obtained for the corresponding group O envelope sequences. A fragment of the group M envelope was amplified on primary PBMCs by a nested PCR with the group M-specific primers envA-envN as outer primers and ED3 and ED14 as inner primers. About 700 bp at the 5' end was sequenced, and phylogenetic analysis of this group M fragment spanning the vpu gene and part of the 5' end of the envelope gene showed that in this region the group M sequence also clusters with the MV-1,NG strains (Fig. 4B) .
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Identification of the predominant viral population. In order to study which viral population was predominant, biological cloning was performed. Only limited amounts of primary PBMCs were available for the three sequential samples obtained from this patient; half of them were used for bulk virus isolation, and DNA was purified from the remaining primary patient material. Therefore, biological clones were prepared starting from the infected PBMCs at the third p24-positive time point from the viral culture, in order to see which viral populations were present in the viral supernatants from the three consecutive samples. More than 90 biological clones were obtained for the three sequential isolates by end point dilution cultures. The presence of the parental and recombinant viruses was checked in PCRs with the discriminating primers in the accessory gene region. Only the M/O recombinant virus was recovered in vitro. However, in the three consecutive plasma samples, group O and group M envelope sequences were amplified by PCR, although the signal was consistently weaker for the group M fragment.
DISCUSSION
In this report we describe for the íkst time a recombination event between viruses belonging to different groups that leads to a viable virus. We documented that this virus, which replicates, well in vitro, also became predominant in vitro. The parental group M virus was detected in primary PBMCs and plasma, with a PCR signal weaker than that for the corresponding fragments of the recombinant M/O virus. On the other hand, the parental group O virus was undetectable in the patient, suggesting that the group O strain replicated even more poorly than the group M strain, which in turn replicated more poorly than the M/O recombinant. The present results demonstrate unequivocally that recombination between viruses with limited homology (65% overall homology) can occur in vivo. Most of the intersubtype mosaic genomes characterized to date originated from geographic regions where multiple subtypes cocirculate, and most of them have a complex genome structure with multiple crossover points (21, 34) . The intergroup recombinant virus presented here has only two b;eakpoints, which induced three major changes, a chimeric vpr gene and a chimeric LTR gene leading to a heterologous T A R -W a t -0 pair.
Recombinant viruses are already contributing substantially to the global pandemic, and the likelihood of generating recombinant viruses will continue to increase as the different HV-1 subtypes spread to all continents (9) . Virtually any isolate, including recombinant viruses, may compete more efficiently in a given region than the original genotype settled if it acquired some selective advantage. However, it remains striking to see how efficiently recombinant viruses have spread among different population groups in different geographic regions, suggesting that they could have a better viral fitness than the parental nonrecombinant strains. In Thailand, where subtypes E (an A/J3 recombinant) and B were initially introduced, subtype E became predominant (18) . In West M i c a subtype A is predominant, with prevalences ranging from 70 to >85% of the strains circulating (9) ; viruses similar to IBNG (an N G recombinant) are highly represented among envelope subtype A viruses (28a). In China, subtype B and C viruses have been introduced, and a recombinant B/C virus is spreading now in different parts of the country (38) . Several reports documented the introduction of subtypes A and B among intravenous-drug users in the former Soviet Union, and a recombinant A/l3 virus is actually rapidly spreading (3, 23) .
Retrovirus recombination can generate viruses with altered biological properties. Experiments in vitro with feline and murine retroviruses have demonstrated that if appropriate selection pressures are applied, mixed infections can generate recombinant viruses with altered tissue tropism, pathogenicity, or host range or with changes in antigenic epitopes (15, 44) . It is also likely that recombination can alter biological properties and pathogenesis among human retroviruses. It is important to monitor the impact of viral recombination on viral properties, since recombination may introduce genetic and biological consequences that are far greater than those resulting from the steady accumulation of single mutations.
The highest diversity between group M and group O viruses is observed in the vpu, em, and nef genes, with 40 to 60% divergence at the nucleotide level, whereas for the other genes, including vpr and LTR, the divergence ranged from 25 to 30% (la, 16, 45) . Therefore, the level of divergence or similarity does not completely explain why the recombination occurred in these parts of the genome, Importantly, recombination between group M and O occurred in vivo. Group O viruses represent a minority of the strains responsible for the m-1 pandemic, and the highest prevalences have been documented i n Cameroon (32) . Recombination between strains with such distant lineages may conmiUte substantially to the emergence of new HIV-1 variants. If these recombinant intergroup viruses have a better fitness than the parental group O viruses, the prevalence of group O sequences could hcrease rapidly. This will have important irnpficatiom for diagnosis of HIV-1 infections by serological and molecular tests ancl for treatment, since differences among susceptibilities to certain antiretroviral drugs have been observed in vitro (7, 2426) . This fact also has important implications for HIV vaccine strategies with live attenuated viruses, which could potentially form recombinants with wild-type strains even if the two viruses are only distantly related. Our finding also opens the hypothesis that distant S N s and €€IV can potentially recombine, particularly i n individuals who are HN positive and exposed to SN by crossspecies transmission or viceversa. Distant S N sequences can thus spread more efficiently into the human population.
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